{"id":"W2912598520","doi":"10.1080/10428194.2018.1498490","title":"Improving CD20 antibody therapy: obinutuzumab in lymphoproliferative disorders","year":2019,"lang":"en","type":"review","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Obinutuzumab; Rituximab; Medicine; Chronic lymphocytic leukemia; CD20; Follicular lymphoma; Lymphoma; Immunology; Antibody; Monoclonal antibody; Lymphoproliferative disorders; Oncology; Internal medicine; Leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.001449366,0.003477426,0.008667381,0.002436136,0.0005157117,0.0005517004,0.001640187,0.003352264,0.0002433046],"category_scores_gemma":[0.0005434183,0.002924192,0.002126365,0.003029808,0.00112487,0.0007702844,0.001254451,0.001151676,0.0008975141],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.2583163,"about_ca_system_score_gemma":0.1749903,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01234051,"about_ca_topic_score_gemma":0.0003249244,"domain_scores_codex":[0.9853822,0.0009418011,0.00349763,0.004278148,0.002277352,0.003622851],"domain_scores_gemma":[0.9918277,0.00160418,0.001460389,0.003424801,0.0003231871,0.001359711],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0009351135,0.0002986401,0.0001458308,0.02574668,0.0009939623,0.001373816,0.0006935504,0.00001908313,0.00004144765,0.0003372179,0.0008213774,0.9685933],"study_design_scores_gemma":[0.07724666,0.001105299,0.000382093,0.02067893,0.001639221,0.006502877,0.0003739727,0.01205098,0.00006777579,0.0001445244,0.8763864,0.003421247],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.02577024,0.9586641,0.00004892615,0.00004661233,0.001071188,0.00712741,0.000180144,0.0005071108,0.006584248],"genre_scores_gemma":[0.00775332,0.9816748,0.000352819,0.0006566182,0.001027817,0.0011718,0.001330052,0.0009141606,0.005118577],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9651721,"threshold_uncertainty_score":0.9998804,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03349201169399164,"score_gpt":0.3415532246328902,"score_spread":0.3080612129388986,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}